Selected research
Market Analysis & Forecast
Global Non-Invasive Helicobacter Pylori Detection Market Analysis and Forecast 2026-2032
Market perspective
The global Non-Invasive Helicobacter Pylori Detection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Non-Invasive Helicobacter Pylori Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Non-Invasive Helicobacter Pylori Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Non-Invasive Helicobacter Pylori Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Non-Invasive Helicobacter Pylori Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Non-Invasive Helicobacter Pylori Detection include Biosynex, Hysen Biotech, Quidel Corporation, Standard Diagnostics, Teco Diagnostics, Assure Tech, Beier Bioengineering, Liming Bio and New Horizon Health, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Non-Invasive Helicobacter Pylori Detection, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Non-Invasive Helicobacter Pylori Detection, also provides the revenue of main regions and countries. Of the upcoming market potential for Non-Invasive Helicobacter Pylori Detection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Non-Invasive Helicobacter Pylori Detection revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Non-Invasive Helicobacter Pylori Detection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Non-Invasive Helicobacter Pylori Detection revenue, projected growth trends, production technology, application and end-user industry.
Non-Invasive Helicobacter Pylori Detection Segment by Company
Biosynex
Hysen Biotech
Quidel Corporation
Standard Diagnostics
Teco Diagnostics
Assure Tech
Beier Bioengineering
Liming Bio
New Horizon Health
Thermo Fisher Scientific
Shanghai Chemtron Biotech
Isia Biotech
Non-Invasive Helicobacter Pylori Detection Segment by Type
Serology Test
Urea Breath Test(UBT)
Stool Antigen Test
Secretion Antibody Test
Others
Non-Invasive Helicobacter Pylori Detection Segment by Application
Medical
Household
Non-Invasive Helicobacter Pylori Detection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Invasive Helicobacter Pylori Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-Invasive Helicobacter Pylori Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Invasive Helicobacter Pylori Detection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Non-Invasive Helicobacter Pylori Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Non-Invasive Helicobacter Pylori Detection company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-Invasive Helicobacter Pylori Detection revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Serology Test
- Urea Breath Test(UBT)
- Stool Antigen Test
- Secretion Antibody Test
- Others
Applications
- Medical
- Household
Companies covered
- Biosynex
- Hysen Biotech
- Quidel Corporation
- Standard Diagnostics
- Teco Diagnostics
- Assure Tech
- Beier Bioengineering
- Liming Bio
- New Horizon Health
- Thermo Fisher Scientific
- Shanghai Chemtron Biotech
- Isia Biotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Non-Invasive Helicobacter Pylori Detection Market by Type
- 1.2.1 Global Non-Invasive Helicobacter Pylori Detection Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Serology Test
- 1.2.3 Urea Breath Test(UBT)
- 1.2.4 Stool Antigen Test
- 1.2.5 Secretion Antibody Test
- 1.2.6 Others
- 1.3 Non-Invasive Helicobacter Pylori Detection Market by Application
- 1.3.1 Global Non-Invasive Helicobacter Pylori Detection Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Medical
- 1.3.3 Household
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Non-Invasive Helicobacter Pylori Detection Market Dynamics
- 2.1 Non-Invasive Helicobacter Pylori Detection Industry Trends
- 2.2 Non-Invasive Helicobacter Pylori Detection Industry Drivers
- 2.3 Non-Invasive Helicobacter Pylori Detection Industry Opportunities and Challenges
- 2.4 Non-Invasive Helicobacter Pylori Detection Industry Restraints
3 Global Growth Perspective
- 3.1 Global Non-Invasive Helicobacter Pylori Detection Market Perspective (2021-2032)
- 3.2 Global Non-Invasive Helicobacter Pylori Detection Growth Trends by Region
- 3.2.1 Global Non-Invasive Helicobacter Pylori Detection Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Non-Invasive Helicobacter Pylori Detection Market Size by Region (2021-2026)
- 3.2.3 Global Non-Invasive Helicobacter Pylori Detection Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Non-Invasive Helicobacter Pylori Detection Revenue by Players
- 4.1.1 Global Non-Invasive Helicobacter Pylori Detection Revenue by Players (2021-2026)
- 4.1.2 Global Non-Invasive Helicobacter Pylori Detection Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Non-Invasive Helicobacter Pylori Detection Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Non-Invasive Helicobacter Pylori Detection Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Non-Invasive Helicobacter Pylori Detection Key Players Headquarters & Area Served
- 4.4 Global Non-Invasive Helicobacter Pylori Detection Players, Product Type & Application
- 4.5 Global Non-Invasive Helicobacter Pylori Detection Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Non-Invasive Helicobacter Pylori Detection Market CR5 and HHI
- 4.6.3 2025 Non-Invasive Helicobacter Pylori Detection Tier 1, Tier 2, and Tier 3
5 Non-Invasive Helicobacter Pylori Detection Market Size by Type
- 5.1 Global Non-Invasive Helicobacter Pylori Detection Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Non-Invasive Helicobacter Pylori Detection Revenue by Type (2021-2032)
- 5.3 Global Non-Invasive Helicobacter Pylori Detection Revenue Market Share by Type (2021-2032)
6 Non-Invasive Helicobacter Pylori Detection Market Size by Application
- 6.1 Global Non-Invasive Helicobacter Pylori Detection Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Non-Invasive Helicobacter Pylori Detection Revenue by Application (2021-2032)
- 6.3 Global Non-Invasive Helicobacter Pylori Detection Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Biosynex
- 7.1.1 Biosynex Company Information
- 7.1.2 Biosynex Business Overview
- 7.1.3 Biosynex Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
- 7.1.4 Biosynex Non-Invasive Helicobacter Pylori Detection Product Portfolio
- 7.1.5 Biosynex Recent Developments
- 7.2 Hysen Biotech
- 7.2.1 Hysen Biotech Company Information
- 7.2.2 Hysen Biotech Business Overview
- 7.2.3 Hysen Biotech Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
- 7.2.4 Hysen Biotech Non-Invasive Helicobacter Pylori Detection Product Portfolio
- 7.2.5 Hysen Biotech Recent Developments
- 7.3 Quidel Corporation
- 7.3.1 Quidel Corporation Company Information
- 7.3.2 Quidel Corporation Business Overview
- 7.3.3 Quidel Corporation Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
- 7.3.4 Quidel Corporation Non-Invasive Helicobacter Pylori Detection Product Portfolio
- 7.3.5 Quidel Corporation Recent Developments
- 7.4 Standard Diagnostics
- 7.4.1 Standard Diagnostics Company Information
- 7.4.2 Standard Diagnostics Business Overview
- 7.4.3 Standard Diagnostics Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
- 7.4.4 Standard Diagnostics Non-Invasive Helicobacter Pylori Detection Product Portfolio
- 7.4.5 Standard Diagnostics Recent Developments
- 7.5 Teco Diagnostics
- 7.5.1 Teco Diagnostics Company Information
- 7.5.2 Teco Diagnostics Business Overview
- 7.5.3 Teco Diagnostics Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
- 7.5.4 Teco Diagnostics Non-Invasive Helicobacter Pylori Detection Product Portfolio
- 7.5.5 Teco Diagnostics Recent Developments
- 7.6 Assure Tech
- 7.6.1 Assure Tech Company Information
- 7.6.2 Assure Tech Business Overview
- 7.6.3 Assure Tech Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
- 7.6.4 Assure Tech Non-Invasive Helicobacter Pylori Detection Product Portfolio
- 7.6.5 Assure Tech Recent Developments
- 7.7 Beier Bioengineering
- 7.7.1 Beier Bioengineering Company Information
- 7.7.2 Beier Bioengineering Business Overview
- 7.7.3 Beier Bioengineering Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
- 7.7.4 Beier Bioengineering Non-Invasive Helicobacter Pylori Detection Product Portfolio
- 7.7.5 Beier Bioengineering Recent Developments
- 7.8 Liming Bio
- 7.8.1 Liming Bio Company Information
- 7.8.2 Liming Bio Business Overview
- 7.8.3 Liming Bio Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
- 7.8.4 Liming Bio Non-Invasive Helicobacter Pylori Detection Product Portfolio
- 7.8.5 Liming Bio Recent Developments
- 7.9 New Horizon Health
- 7.9.1 New Horizon Health Company Information
- 7.9.2 New Horizon Health Business Overview
- 7.9.3 New Horizon Health Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
- 7.9.4 New Horizon Health Non-Invasive Helicobacter Pylori Detection Product Portfolio
- 7.9.5 New Horizon Health Recent Developments
- 7.10 Thermo Fisher Scientific
- 7.10.1 Thermo Fisher Scientific Company Information
- 7.10.2 Thermo Fisher Scientific Business Overview
- 7.10.3 Thermo Fisher Scientific Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
- 7.10.4 Thermo Fisher Scientific Non-Invasive Helicobacter Pylori Detection Product Portfolio
- 7.10.5 Thermo Fisher Scientific Recent Developments
- 7.11 Shanghai Chemtron Biotech
- 7.11.1 Shanghai Chemtron Biotech Company Information
- 7.11.2 Shanghai Chemtron Biotech Business Overview
- 7.11.3 Shanghai Chemtron Biotech Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
- 7.11.4 Shanghai Chemtron Biotech Non-Invasive Helicobacter Pylori Detection Product Portfolio
- 7.11.5 Shanghai Chemtron Biotech Recent Developments
- 7.12 Isia Biotech
- 7.12.1 Isia Biotech Company Information
- 7.12.2 Isia Biotech Business Overview
- 7.12.3 Isia Biotech Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
- 7.12.4 Isia Biotech Non-Invasive Helicobacter Pylori Detection Product Portfolio
- 7.12.5 Isia Biotech Recent Developments
8 North America
- 8.1 North America Non-Invasive Helicobacter Pylori Detection Revenue (2021-2032)
- 8.2 North America Non-Invasive Helicobacter Pylori Detection Revenue by Type (2021-2032)
- 8.2.1 North America Non-Invasive Helicobacter Pylori Detection Revenue by Type (2021-2026)
- 8.2.2 North America Non-Invasive Helicobacter Pylori Detection Revenue by Type (2027-2032)
- 8.3 North America Non-Invasive Helicobacter Pylori Detection Revenue Share by Type (2021-2032)
- 8.4 North America Non-Invasive Helicobacter Pylori Detection Revenue by Application (2021-2032)
- 8.4.1 North America Non-Invasive Helicobacter Pylori Detection Revenue by Application (2021-2026)
- 8.4.2 North America Non-Invasive Helicobacter Pylori Detection Revenue by Application (2027-2032)
- 8.5 North America Non-Invasive Helicobacter Pylori Detection Revenue Share by Application (2021-2032)
- 8.6 North America Non-Invasive Helicobacter Pylori Detection Revenue by Country
- 8.6.1 North America Non-Invasive Helicobacter Pylori Detection Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Non-Invasive Helicobacter Pylori Detection Revenue by Country (2021-2026)
- 8.6.3 North America Non-Invasive Helicobacter Pylori Detection Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Non-Invasive Helicobacter Pylori Detection Revenue (2021-2032)
- 9.2 Europe Non-Invasive Helicobacter Pylori Detection Revenue by Type (2021-2032)
- 9.2.1 Europe Non-Invasive Helicobacter Pylori Detection Revenue by Type (2021-2026)
- 9.2.2 Europe Non-Invasive Helicobacter Pylori Detection Revenue by Type (2027-2032)
- 9.3 Europe Non-Invasive Helicobacter Pylori Detection Revenue Share by Type (2021-2032)
- 9.4 Europe Non-Invasive Helicobacter Pylori Detection Revenue by Application (2021-2032)
- 9.4.1 Europe Non-Invasive Helicobacter Pylori Detection Revenue by Application (2021-2026)
- 9.4.2 Europe Non-Invasive Helicobacter Pylori Detection Revenue by Application (2027-2032)
- 9.5 Europe Non-Invasive Helicobacter Pylori Detection Revenue Share by Application (2021-2032)
- 9.6 Europe Non-Invasive Helicobacter Pylori Detection Revenue by Country
- 9.6.1 Europe Non-Invasive Helicobacter Pylori Detection Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Non-Invasive Helicobacter Pylori Detection Revenue by Country (2021-2026)
- 9.6.3 Europe Non-Invasive Helicobacter Pylori Detection Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Non-Invasive Helicobacter Pylori Detection Revenue (2021-2032)
- 10.2 China Non-Invasive Helicobacter Pylori Detection Revenue by Type (2021-2032)
- 10.2.1 China Non-Invasive Helicobacter Pylori Detection Revenue by Type (2021-2026)
- 10.2.2 China Non-Invasive Helicobacter Pylori Detection Revenue by Type (2027-2032)
- 10.3 China Non-Invasive Helicobacter Pylori Detection Revenue Share by Type (2021-2032)
- 10.4 China Non-Invasive Helicobacter Pylori Detection Revenue by Application (2021-2032)
- 10.4.1 China Non-Invasive Helicobacter Pylori Detection Revenue by Application (2021-2026)
- 10.4.2 China Non-Invasive Helicobacter Pylori Detection Revenue by Application (2027-2032)
- 10.5 China Non-Invasive Helicobacter Pylori Detection Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Non-Invasive Helicobacter Pylori Detection Revenue (2021-2032)
- 11.2 Asia Non-Invasive Helicobacter Pylori Detection Revenue by Type (2021-2032)
- 11.2.1 Asia Non-Invasive Helicobacter Pylori Detection Revenue by Type (2021-2026)
- 11.2.2 Asia Non-Invasive Helicobacter Pylori Detection Revenue by Type (2027-2032)
- 11.3 Asia Non-Invasive Helicobacter Pylori Detection Revenue Share by Type (2021-2032)
- 11.4 Asia Non-Invasive Helicobacter Pylori Detection Revenue by Application (2021-2032)
- 11.4.1 Asia Non-Invasive Helicobacter Pylori Detection Revenue by Application (2021-2026)
- 11.4.2 Asia Non-Invasive Helicobacter Pylori Detection Revenue by Application (2027-2032)
- 11.5 Asia Non-Invasive Helicobacter Pylori Detection Revenue Share by Application (2021-2032)
- 11.6 Asia Non-Invasive Helicobacter Pylori Detection Revenue by Country
- 11.6.1 Asia Non-Invasive Helicobacter Pylori Detection Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Non-Invasive Helicobacter Pylori Detection Revenue by Country (2021-2026)
- 11.6.3 Asia Non-Invasive Helicobacter Pylori Detection Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Non-Invasive Helicobacter Pylori Detection Revenue (2021-2032)
- 12.2 SAMEA Non-Invasive Helicobacter Pylori Detection Revenue by Type (2021-2032)
- 12.2.1 SAMEA Non-Invasive Helicobacter Pylori Detection Revenue by Type (2021-2026)
- 12.2.2 SAMEA Non-Invasive Helicobacter Pylori Detection Revenue by Type (2027-2032)
- 12.3 SAMEA Non-Invasive Helicobacter Pylori Detection Revenue Share by Type (2021-2032)
- 12.4 SAMEA Non-Invasive Helicobacter Pylori Detection Revenue by Application (2021-2032)
- 12.4.1 SAMEA Non-Invasive Helicobacter Pylori Detection Revenue by Application (2021-2026)
- 12.4.2 SAMEA Non-Invasive Helicobacter Pylori Detection Revenue by Application (2027-2032)
- 12.5 SAMEA Non-Invasive Helicobacter Pylori Detection Revenue Share by Application (2021-2032)
- 12.6 SAMEA Non-Invasive Helicobacter Pylori Detection Revenue by Country
- 12.6.1 SAMEA Non-Invasive Helicobacter Pylori Detection Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Non-Invasive Helicobacter Pylori Detection Revenue by Country (2021-2026)
- 12.6.3 SAMEA Non-Invasive Helicobacter Pylori Detection Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst